“VEMURAFENIB AS A SELECTIVE INHIBITOR OF THE SERINE/THREONINE-PROTEIN KINASE B-RAF, USED IN THE TREATMENT OF MELANOMA”, Prospect. Pharm. Sci., vol. 14, no. 8, pp. 52–56, Dec. 2016, doi: 10.56782/pps.117.